NPI 1962433839: Open Payments
NPI 1962433839. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 16 payments from 3 companies in 2025. Trend: 2023 $465 · 2024 $516 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $215 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: UBRELVY, QULIPTA, CREON, JOURNAVX, OFEV, LINZESS.
